STOCK TITAN

SOPH (NASDAQ: SOPH) insider Zhenyu Xu plans Form 144 share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Zhenyu Xu has filed a Form 144 to sell 4,608 shares of SOPH common stock. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange, with an aggregate market value of $25,113.60 and an approximate sale date of 01/20/2026.

The shares to be sold include stock acquired as restricted stock units on 01/18/2026 (608 shares) and founders shares acquired on 06/20/2012 (4,000 shares. In the past three months, Xu has already completed multiple Rule 10b5-1 sales of SOPH common stock, including 4,000 shares on 01/13/2026 for $20,682.40, along with several smaller transactions.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does SOPH's Form 144 filed by Zhenyu Xu disclose?

The Form 144 discloses that Zhenyu Xu intends to sell 4,608 shares of SOPH common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $25,113.60 and an approximate sale date of 01/20/2026.

How many SOPH shares are planned to be sold and at what value?

The notice covers a planned sale of 4,608 common shares of SOPH with an aggregate market value of $25,113.60 as listed in the securities information section.

How and when did Zhenyu Xu acquire the SOPH shares being sold?

The securities to be sold consist of 608 common shares acquired on 01/18/2026 as restricted stock units from the issuer and 4,000 common shares acquired on 06/20/2012 as founders shares from the issuer, with payment dates matching the acquisition dates.

What recent 10b5-1 sales of SOPH shares has Zhenyu Xu made?

Over the past three months, Rule 10b5-1 sales for Zhenyu Xu include multiple transactions in SOPH common stock, such as 4,000 shares sold on 01/13/2026 for $20,682.40, 3,000 shares on 01/06/2026 for $14,296.20, 2,006 shares on 01/05/2026 for $9,245.65, 608 shares on 12/19/2025 for $2,817.29, and 609 shares on 11/19/2025 for $2,450.74.

Through which broker and exchange will the SOPH shares be sold?

The planned sale of 4,608 SOPH common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, with trading on the NASDAQ exchange.

How many SOPH shares are outstanding according to this Form 144?

The filing states that the number of SOPH common shares outstanding is 67,847,058 at the time referenced in the securities information table.

What representation does the seller make about information on the issuer?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed, as required under the Form 144 instructions.

Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

354.16M
63.48M
6.46%
48.2%
0.06%
Health Information Services
Healthcare
Link
Switzerland
Rolle